Ann: Mach7 signs 5 year licence agreement with Penn State Hershey, page-10

This is the one stock I continue to hold that seems to be ticking all the boxes and lining everything up nicely: product, partnerships and key acquisition, growth technology in health, global market, staff and new leadership with the right pedigree and experience.

I'm just glad to see that all the ducks are slowly getting into line and the company is doing exactly what it should be doing - getting down to business and generating new revenues.

Why is this not reflecting in the share price? I'm not sure, but not too concerned if everything stays on track.

Good work Mach7.